Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sfunga Therapeutics

Sfunga Therapeutics
PRIVATE STATUS
Seed LATEST DEAL TYPE
1 INVESTORS
Description

Provider of clinical research and development services focused on the treatment of systemic and life-threatening fungal infections. The company's services focus on the improvement of Amphotericin B drug, enabling its clients to receive a broad-spectrum of antifungal drug that is completely non-toxic in mammalian cells.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Delivery
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sfunga Therapeutics’s full profile, request a free trial.

Sfunga Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 22-Jan-2018 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Sfunga Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
IllinoisVENTURES Venture Capital Minority 000 0000 000000 0